Rocuronium Induction Dosing
For routine tracheal intubation in adults with no significant medical history, administer rocuronium 0.6 mg/kg intravenously, which provides excellent intubation conditions within 60-90 seconds and approximately 30-45 minutes of neuromuscular blockade. 1
Standard Induction Dose
The FDA-approved and guideline-recommended dose for routine intubation is 0.6 mg/kg (equivalent to 2 x ED95), which achieves:
- Onset: Neuromuscular block sufficient for intubation (≥80% block) in a median of 1 minute (range 0.4-6 minutes) 1
- Intubation timing: Most patients can be intubated within 2 minutes, with maximum blockade achieved in less than 3 minutes 1
- Duration: Approximately 31 minutes (range 15-85 minutes) of clinical relaxation under opioid/nitrous oxide/oxygen anesthesia 1
Alternative Dosing Options
Lower Dose (0.45 mg/kg)
A reduced dose may be used when shorter duration is desired 1:
- Onset is slightly slower: median 1.3 minutes (range 0.8-6.2 minutes) 1
- Duration is shorter: approximately 22 minutes (range 12-31 minutes) 1
- Critical caveat: About 16% of patients achieve <90% block and may have more rapid recovery (12-15 minutes) 1
Rapid Sequence Intubation
For RSI scenarios, higher doses of 0.9-1.2 mg/kg are recommended to achieve intubation conditions comparable to succinylcholine 2, 1:
- The European Society of Anaesthesiology recommends at least 0.9 mg/kg for RSI 3
- Doses of 0.9-1.2 mg/kg can be administered without adverse cardiovascular effects 1
- A Cochrane meta-analysis found that succinylcholine provides superior intubation conditions compared to standard rocuronium doses, but when rocuronium >0.9 mg/kg is compared to succinylcholine 1.0 mg/kg, no superiority of succinylcholine was demonstrated 2
Critical Administration Requirements
Personnel and equipment readiness 3:
- Experienced clinicians with airway management skills must be present 3, 1
- Age-appropriate equipment for suctioning, oxygenation, intubation, and ventilation must be immediately available 3
- Peripheral nerve stimulator should be used to monitor drug effect 1
Essential safety considerations 4, 3:
- Rocuronium provides NO sedation, analgesia, or amnesia—appropriate sedative and analgesic medications must be administered concurrently 4, 3, 1
- Flush IV tubing with saline before administering rocuronium after other medications to avoid precipitation 3
- Store rocuronium with cap and ferrule intact to minimize risk of medication errors 1
Factors Affecting Dosing
Inhalational anesthetics potentiate rocuronium's effect 4, 1:
- Under halothane, isoflurane, or enflurane anesthesia, expect extended duration of clinical relaxation 1
- Infusion rates may need reduction by 30-50% during inhalational anesthesia 1
Special populations 3:
- Renal or hepatic failure: Initial dose does NOT need modification, though duration may be prolonged 3
- Cardiovascular instability: Standard dose of 0.6 mg/kg can still be used as rocuronium has minimal cardiovascular effects 3
- Patients on pyridostigmine: Initial dose should not be modified, but subsequent maintenance doses require 50-75% reduction 4
Clinical Context: Dose Selection Algorithm
- Routine elective intubation: Use 0.6 mg/kg 1
- Short procedures requiring shorter duration: Consider 0.45 mg/kg 1
- Rapid sequence intubation: Use 0.9-1.2 mg/kg 2, 3, 1
- When succinylcholine is contraindicated in RSI: Use rocuronium 0.9-1.2 mg/kg with sugammadex immediately available 2
Common Pitfalls to Avoid
- Underdosing in RSI: Using 0.6 mg/kg for RSI may result in suboptimal intubation conditions; doses ≥0.9 mg/kg are needed 2, 3
- Forgetting concurrent sedation: Rocuronium alone provides no sedation—always administer appropriate sedatives/analgesics 4, 3, 1
- Inadequate monitoring: Failure to use neuromuscular monitoring can lead to residual blockade, which occurs in 28% of pediatric patients and is a concern in adults 4
- Premature intubation attempt: Wait at least 60-90 seconds after administration for adequate onset 1